These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37695066)

  • 21. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
    Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
    Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic evidence for host specificity in the adhesin-encoding genes hxaA of Helicobacter acinonyx, hnaA of H. nemestrinae and hpaA of H. pylori.
    Evans DG; Lampert HC; Nakano H; Eaton KA; Burnens AP; Bronsdon MA; Evans DJ
    Gene; 1995 Sep; 163(1):97-102. PubMed ID: 7557486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and Validation of Chicken Immune scFv Antibody Library against
    Gong Y; Chen X; Fan J; Sun L; He L; Wang H; Yan X; Zhang J
    Microorganisms; 2024 Jun; 12(6):. PubMed ID: 38930530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel nanobody against urease activity of Helicobacter pylori.
    Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
    Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori.
    Banga Ndzouboukou JL; Lei Q; Ullah N; Zhang Y; Hao L; Fan X
    Helicobacter; 2021 Feb; 26(1):e12758. PubMed ID: 33259676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bamboo Shark as a Small Animal Model for Single Domain Antibody Production.
    Wei L; Wang M; Xiang H; Jiang Y; Gong J; Su D; Al Azad MAR; Dong H; Feng L; Wu J; Chan LL; Yang N; Shi J
    Front Bioeng Biotechnol; 2021; 9():792111. PubMed ID: 34957081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization.
    Xi X; Xiao G; An G; Liu L; Liu X; Hao P; Wang JY; Song D; Yu W; Gu Y
    Front Immunol; 2023; 14():1062656. PubMed ID: 36855630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restriction fragment length polymorphism of adhesin gene hpaA from different Helicobacter pylori strains of Chongqing, China.
    Hong Y; Mao XH; Zeng WK; Ma LM; Jing SR; Zou QM
    World J Gastroenterol; 2005 May; 11(17):2647-52. PubMed ID: 15849827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey on chimeric UreB
    Chirani AS; Ghazi M; Goudarzi M; Peerayeh SN; Soleimanjahi H; Dadashi M; Hajikhani B
    Comput Biol Chem; 2018 Oct; 76():42-52. PubMed ID: 29929167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal immunization with immunodominant epitope peptides derived from HpaA conjugated with CpG adjuvant protected mice against Helicobacter pylori infection.
    Yang WC; Sun HW; Sun HQ; Yuan HM; Li B; Li HB; Hu J; Yang Y; Zou QM; Guo H; Wu C; Chen L
    Vaccine; 2018 Oct; 36(42):6301-6306. PubMed ID: 30217524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
    Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
    Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dominant CD4(+) T-cell response to Helicobacter pylori reduces risk for gastric disease in humans.
    Chen L; Li B; Yang WC; He JL; Li NY; Hu J; He YF; Yu S; Zhao Z; Luo P; Zhang JY; Li HB; Zeng M; Lu DS; Li BS; Guo H; Yang SM; Guo G; Mao XH; Chen W; Wu C; Zou QM
    Gastroenterology; 2013 Mar; 144(3):591-600. PubMed ID: 23232294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis.
    Kovaleva M; Johnson K; Steven J; Barelle CJ; Porter A
    Front Immunol; 2017; 8():1121. PubMed ID: 28993766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody.
    Cheong WS; Leow CY; Abdul Majeed AB; Leow CH
    Int J Biol Macromol; 2020 Mar; 147():369-375. PubMed ID: 31926922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein.
    O'Toole PW; Janzon L; Doig P; Huang J; Kostrzynska M; Trust TJ
    J Bacteriol; 1995 Nov; 177(21):6049-57. PubMed ID: 7592366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern.
    Valdovino-Navarro BJ; Dueñas S; Flores-Acosta GI; Gasperin-Bulbarela J; Bernaldez-Sarabia J; Cabanillas-Bernal O; Cervantes-Luevano KE; Licea-Navarro AF
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro study of the biological activities and immunogenicity of recombinant adhesin of Heliobacter pylori rHpaA].
    Chen Y; Wang J; Shi L
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):276-9. PubMed ID: 11798887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.
    Fernández-Quintero ML; Fischer AM; Kokot J; Waibl F; Seidler CA; Liedl KR
    Front Immunol; 2022; 13():953917. PubMed ID: 36177031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic Lipopeptide Enhances Protective Immunity Against
    Xue RY; Guo MF; Guo L; Liu C; Li S; Luo J; Nie L; Ji L; Ma CJ; Chen DQ; Sun S; Jin Z; Zou QM; Li HB
    Front Immunol; 2019; 10():1372. PubMed ID: 31258538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.